Cargando…
Development of (111)In-labeled porphyrins for SPECT imaging
OBJECTIVE(S): The aim of this research was the development of (111)In-labeled porphyrins as possible radiopharmaceuticals for the imaging of tumors. METHODS: Ligands, 5, 10, 15, 20-tetrakis (3, 5-dihydroxyphenyl) porphyrin) (TDHPP), 5, 10, 15, 20-tetrakis (4-hydroxyphenyl) porphyrin (THPP) and 5, 10...
Autores principales: | Sadeghi, Shaghayegh, Mirzaei, Mohammad, Rahimi, Mohammad, Jalilian, Amir R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asia Oceania Journal of Nuclear Medicine & Biology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937704/ https://www.ncbi.nlm.nih.gov/pubmed/27408865 |
Ejemplares similares
-
Evaluation of a (68)Ga-Labeled DOTA-Tetrazine as a PET Alternative to (111)In-SPECT Pretargeted Imaging
por: Edem, Patricia E., et al.
Publicado: (2020) -
Whole‐body Autoradiography of Tumor‐bearing Hamsters with a New Tumor Imaging Agent, Indium‐111‐labeled Porphyrin
por: Yamazaki, Kosuke, et al.
Publicado: (1988) -
A topological analysis of targeted In-111 uptake in SPECT images of murine tumors
por: Damiano, David B., et al.
Publicado: (2017) -
Assessment of Four Scatter Correction Methods in In-111 SPECT Imaging: A Simulation Study
por: Noori-Asl, Mahsa
Publicado: (2020) -
Automatic and manual image fusion of (111)In-pentetreotide SPECT and diagnostic CT in neuroendocrine tumor imaging – An evaluation
por: Hedlund, Elisabeth, et al.
Publicado: (2010)